Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells.

Abstract

No abstract available.

EDRN PI Authors
Medline Author List
  • Blomquist TM
  • Craig DJ
  • Crawford EL
  • Khuder SA
  • Morrison T
  • Willey JC
  • Wu L
  • Xu J
PubMed ID
Appears In